Gomez, Divina D.
HRN: 26-41-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/18/2025
02/19/2025
IV
500mg
500mg Iv Q8 X3dosss
S/p Primary Lstcs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes